Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Don't Sleep On DTC Compliance: FDA Dings Zolpimist Superiority Claim Vs Ambien

Nov 24 2017

• By Brenda Sandburg

FDA entrance sign 2016

Related Content

Opioid Warning Letter To Cipher Likely Easy Call For US FDA

Sep 06 2017

Contrave TV Ad's Slimmed Down Adverse Events Draw FDA Rebuke

May 25 2017

Deal Notes: GlycoMimetics/Pfizer, Pharmacyclics/Servier, TG Therapeutics/Rhizen, Takeda/BioMotiv, Amherst/NovaDel

Sep 29 2014

FDA’s Rx Promo Citations Rise Slightly In 2016; Investigational Drug Promos Scrutinized

Jan 09 2017

Related Companies

Amherst Pharmaceuticals, LLC

Sanofi

NovaDel Pharma, Inc.

Orexigen Therapeutics, Inc.

Cipher Pharmaceuticals Inc.

Pacira BioSciences, Inc.

Additional Topics

United States Regulation FDA Advertising, Marketing & Sales BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window